Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Pluto Biosciences
AddedFeb 16, 2024
UpdatedJun 18, 2026
Pluto Biosciences

Pluto Biosciences

Seed

Pluto: A B2B SaaS platform for collaborative management, analysis, and visualization of biological data.

HQ
Denver, CO, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Pluto Biosciences, founded with the mission to revolutionize biological data management, offers a B2B SaaS platform designed for collaborative analysis and visualization of biological data. The company's core vision is to accelerate scientific discovery and innovation in biotechnology, drug discovery, and academic research. Pluto's platform enables teams to translate raw data into actionable insights, facilitating processes such as target identification, biomarker discovery, and comparative translational studies.

Notable figures affiliated with Pluto Biosciences include experienced professionals from the biotechnology and software industries. The company has attracted investments from prominent venture capital firms focused on life sciences and technology. Key achievements include the successful deployment of their platform in various research institutions and biotech companies, significantly reducing the time required for data analysis and increasing reproducibility and data accessibility. Pluto Biosciences' impact is marked by its contribution to faster scientific discoveries and higher-quality research publications.

Pluto Biosciences - Similar Companies

Insightful Science logo

Insightful Science

TetraScience logo

TetraScience

tetrascience.com

Benchling logo

Benchling

benchling.com

Omix.ai logo

Omix.ai

Datirium logo

Datirium

datirium.com

PipeBio logo

PipeBio

Plutis logo

Plutis

plutis.io

LatchBio logo

LatchBio

latch.bio

Watershed Informatics logo

Watershed Informatics

watershed.bio

BioTuring logo

BioTuring

bioturing.com

Scispot logo

Scispot

scispot.io

Via Scientific logo

Via Scientific

viascientific.com

Ganymede logo

Ganymede

ganymede.bio

Bioz logo

Bioz

bioz.com

Basepair logo

Basepair

basepairtech.com

Pluto Biosciences - Quick Facts

Who are Pluto Biosciences' competitors?

Companies similar to Pluto Biosciences include Insightful Science, TetraScience, Benchling and Omix.ai.

When was Pluto Biosciences founded?

Pluto Biosciences was founded in 2020.

Where is Pluto Biosciences' headquarters located?

Pluto Biosciences' headquarters is located in Denver, CO, US.

When was Pluto Biosciences' last funding round?

Pluto Biosciences' most recent funding round was for $3.7M (USD) in May 2023.

How much has Pluto Biosciences raised to-date?

As of May 2, 2023, Pluto Biosciences has raised a total of $4.7M (USD).

How many employees does Pluto Biosciences have?

Pluto Biosciences has 29 employees as of Feb 5, 2024.

Pluto Biosciences - Classification

Ownership
  • Venture Capital
Technology
  • Analytics
  • Data Visualization
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
  • Small Business
Main Product
  • Data Management
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software